Louis Lau

Louis Lau

Auto-generated profile, based on publicly available information

Louis Lau

Center for Systems Immunology and Department of Immunology, University of Pittsburgh

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
KLKevin Louis
Kevin Louis
EBElodie Bailly
Elodie Bailly
CMCamila Macedo
Camila Macedo
LLLouis Lau
Louis Lau
BRBala Ramaswami
Bala Ramaswami
DMDiana M. Metes
Diana M. Metes
Alloimmune responses driven by donor-specific antibodies (DSAs) can lead to antibody-mediated rejection (ABMR) in organ transplantation. Yet, the cellular states underlying alloreactive B cell responses and the molecular components controlling them remain unclear. Using high-dimensional profiling of B cells in a cohort of 96 kidney transplant recipients, we identified expanded numbers of CD27 + CD21 – activated memory (AM) B cells that expressed the transcription factor T-bet in patients who developed DSAs and progressed to ABMR. Notably, AM cells were less frequent in DSA + ABMR – patients and at baseline levels in DSA – patients. RNA-Seq analysis of AM cells in patients undergoing ABMR revealed these cells to be poised for plasma cell differentiation and to express restricted IGHV sequences reflective of clonal expansion. In addition to T-bet, AM cells manifested elevated expression of interferon regulatory factor 4 and Blimp1, and upon coculture with autologous T follicular helper cells, differentiated into DSA-producing plasma cells in an IL-21–dependent manner. The frequency of AM cells was correlated with the timing and severity of ABMR manifestations. Importantly, T-bet + AM cells were detected within kidney allografts along with their restricted IGHV sequences. This study delineates a pivotal role for AM cells in promoting humoral responses and ABMR in organ transplantation and highlights them as important therapeutic targets.

1 August 2015 in Journal of Clinical Virology
Verified
Journal Article
Closed access
LLLouis Lau
Louis Lau
AGAngela M. Green
Angela M. Green
ABAngel Balmaseda
Angel Balmaseda
EHEva Harris
Eva Harris

17 August 2026 in eLife preprints
Verified
Preprint
Open access
PDF file
LLLouis C Lau
Louis C Lau
SLSneha Lal
Sneha Lal
JFJingyu Fan
Jingyu Fan
NPNicholas Pease
Nicholas Pease
HSHarinder Singh
Harinder Singh
The transcription factors IRF4 and BLIMP1 (PRDM1) promote plasma cell (PC) differentiation by repressing B cell identity genes while inducing the unfolded protein response, ER/Golgi biogenesis, and immunoglobulin secretion. How IRF4 and BLIMP1 partition and coordinate their genomic activities during plasma cell differentiation remains unresolved. Using naïve human B cells and a stepwise in vitro differentiation system, we performed CRISPR/Cas9 perturbations of IRF4 or PRDM1 in plasma cell precursors followed by single-cell RNA sequencing. Despite their mutually reinforced expression and shared recognition of related IRF-family motifs (ISREs and EICEs), loss of IRF4, but not of BLIMP1, yielded a stunted intermediate with incomplete silencing of B cell identity genes and defective induction of the secretory program. Multiome profiling, base-pair-resolution motif modeling, CUT&RUN, and DNA-binding assays identified non-conserved nucleotides within ISRE/EICE motifs that discriminate IRF4 from BLIMP1 binding. These findings reveal a motif-lexicon-dependent IRF4-BLIMP1 interplay, in which IRF4 first acts independently and then in concert with BLIMP1. This regulatory logic may also underlie programming of additional lymphocyte effector states.

24 October 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BMBenjamin M. Murter
Benjamin M. Murter
SRSean C. Robinson
Sean C. Robinson
HBHridesh Banerjee
Hridesh Banerjee
LLLouis Lau
Louis Lau
UUUzodinma N. Uche
Uzodinma N. Uche
LKLawrence P. Kane
Lawrence P. Kane
The protein known as PI3K-interacting protein (PIK3IP1), or transmembrane inhibitor of PI3K (TrIP), is highly expressed by T cells and can modulate PI3K activity in these cells. Several studies have also revealed that TrIP is rapidly downregulated following T cell activation. However, it is unclear how this downregulation is controlled. Using a novel monoclonal antibody that robustly stains cell-surface TrIP, we demonstrate that TrIP is lost from the surface of activated T cells in a manner dependent on the strength of signaling through the T cell receptor and specific downstream signaling pathways, in particular classical PKC isoforms. TrIP expression returns by 24 h after stimulation, suggesting that it may play a role in resetting T cell receptor signaling at later time points. We also provide evidence that ADAM family proteases are required for both constitutive and stimulation-induced downregulation of TrIP in T cells. Finally, by expressing truncated forms of TrIP in cells, we identify the region in the extracellular stalk domain of TrIP that is targeted for proteolytic cleavage.

19 June 2026 in bioRxiv
Verified
Preprint
Open access
LLLouis C. Lau
Louis C. Lau
SLSneha Lal
Sneha Lal
JFJingyu Fan
Jingyu Fan
NPNicholas Pease
Nicholas Pease
HSHarinder Singh
Harinder Singh
The transcription factors IRF4 and BLIMP1 ( PRDM1 ) promote plasma cell (PC) differentiation by repressing B cell identity genes while inducing the unfolded protein response, ER/Golgi biogenesis, and immunoglobulin secretion. How IRF4 and BLIMP1 partition and coordinate their genomic activities during plasma cell differentiation remains unresolved. Using naïve human B cells and a stepwise in vitro differentiation system, we performed CRISPR/Cas9 perturbations of IRF4 or PRDM1 in plasma cell precursors followed by single-cell RNA sequencing. Despite their mutually reinforced expression and shared recognition of related IRF-family motifs (ISREs and EICEs), loss of IRF4, but not of BLIMP1, yielded a stunted intermediate with incomplete silencing of B cell identity genes and defective induction of the secretory program. Multiome profiling, base-pair-resolution motif modeling, CUT&RUN, and DNA-binding assays identified non-conserved nucleotides within ISRE/EICE motifs that discriminate IRF4 from BLIMP1 binding. These findings reveal a motif-lexicon-dependent IRF4-BLIMP1 interplay, in which IRF4 first acts independently and then in concert with BLIMP1. This regulatory logic may also underlie programming of additional lymphocyte effector states.